10 results
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... diseases - Severe ... jirovecii pneumonia, id ... #Pharmacology # ... Management #Treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
INR Warfarin dosage ... #management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
#differential #algorithm ... #management #cardiology ... #treatment #table ... #heartfailure #chf ... icu #clinical #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
months (AII), with dosage ... with ARV (see Table ... IDSA #Prevention #Treatment ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
diseases consultation ... to guide management ... IDSA #Prevention #Treatment ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
a person with infectious ... Please refer to the table ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
Cryptococcosis in HIV-AIDS Treatment ... and a negative CSF ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Treating HHV-8 Diseases—Kaposi ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
PO daily (BI) (dosage ... please refer to Table ... IDSA #Prevention #Treatment ... #infections #HIVAIDS ... #pharmacology